GLP-1, Incretin Mimetics and DPP 4 Inhibitors: New Ways in the Treatment of Type 2 Diabetes

By  

Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol. 5, Iss. 6, 2005-12 ,pp. : 485-497

Bentham Science Publishers

Access to resources Recommend Favorite

Myocardial Ischemia/Reperfusion Injury: Potential of TRPV1 Agonists as Cardioprotective Agents

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 14, Iss. 1, 2014-03 ,pp. : 71-78

Bentham Science Publishers

Access to resources Recommend Favorite

Ca²⁺ Signaling by Cholinergic and ₁-Adrenergic Agonists Is Up-Regulated in Lacrimal and Submandibular Glands in a Murine Model of Sjögren's Syndrome

By Zoukhri I.   Hodges R.R.   Rawe I.M.   Dartt D.A.  

Clinical Immunology, Vol. 89, Iss. 2, 1998-11 ,pp. : 134-140

Academic Press

Access to resources Recommend Favorite

How Satiety Factors Reach CNS Appetite Centers

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 8, Iss. 4, 2008-12 ,pp. : 286-891

Bentham Science Publishers

Access to resources Recommend Favorite

β₂-Agonists: Introduction

By Anderson Sandra  

Clinical Reviews in Allergy and Immunology, Vol. 31, Iss. 2-3, 2006-06 ,pp. : 103-105

Humana Press, Inc

Access to resources Recommend Favorite